Hong Kong Stock Movement | InnoCare Pharma (09969.HK) rises over 4%, turns profitable in the first three quarters, core product orelabrutinib continues to ramp up
Zhitong Finance APP has learned that InnoCare Pharma (09969.HK) rose over 4%, up 5.08% as of press time, at HK$14.49, with a turnover of HK$34.8642 million.
Latest
